KI
Ing Lorenzini, Kuntheavy
| Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
|---|---|---|---|---|---|---|---|
| Antiviral Use in Mild-to-Moderate SARS-CoV-2 Infections during the Omicron Wave in Geriatric Patients | Viruses |  | 2024 | 126 | 124 | ||
| Practice of CYP450 genotyping and phenotyping in children in a real-life setting | Frontiers in pharmacology | | 2023 | 77 | 176 | ||
| Relapses of Immune Thrombocytopenia after the Second and Booster Doses of BNT162b2 Vaccine | Acta haematologica | | 2023 | 69 | 104 | ||
| A severe case of rhabdomyolysis after Moderna mRNA anti‐COVID ‐19 vaccine with a literature review | Clinical case reports | | 2023 | 148 | 143 | ||
| Opioid‐related adverse drug reactions in patients visiting the emergency division of a tertiary hospital | Pharmacology research & perspectives | | 2022 | 153 | 98 | ||
| Dexamethasone and Number of Days Alive Without Life Support in Adults With COVID-19 and Severe Hypoxemia | JAMA |  | 2022 | 170 | 0 | ||
| Dexamethasone exposure in normal-weight and obese hospitalized COVID-19 patients: An observational exploratory trial | Clinical and translational science | | 2022 | 152 | 123 | ||
| Case Report: Opioid Use Disorder Associated With Low/Moderate Dose of Loperamide in an Intellectual Disability Patient With CYP3A and P-Glycoprotein Reduced Activity | Frontiers in psychiatry | | 2022 | 105 | 119 | ||
| Fracture risk following an atypical femoral fracture | Journal of bone and mineral research | | 2022 | 270 | 298 | ||
| CYP450 Genotype-Phenotype Concordance Using the Geneva Micrococktail in a Clinical Setting | Frontiers in pharmacology | | 2021 | 280 | 291 | ||
| Various approaches to postmarketing drug safety monitoring | | 2021 | 273 | 590 | |||
| Outcomes of drug exposition during pregnancy: Analysis from a teratology information service | European Journal of Obstetrics, Gynecology, and Reproductive Biology | | 2020 | 277 | 4 | ||
| Direct-acting antiviral interactions with opioids, alcohol or illicit drugs of abuse in HCV-infected patients | Liver International | | 2020 | 350 | 333 | ||
| Automatic Classification of Discharge Letters to Detect Adverse Drug Reactions | Studies in Health Technology and Informatics | | 2020 | 468 | 188 | ||
| Evaluation of Phenotypic and Genotypic Variations of Drug Metabolising Enzymes and Transporters in Chronic Pain Patients Facing Adverse Drug Reactions or Non-Response to Analgesics: A Retrospective Study | Journal of Personalized Medicine | | 2020 | 356 | 102 | ||
| Importance et particularités de la pharmacovigilance en pédiatrie | Revue médicale suisse | | 2019 | 421 | 430 | ||
| Severe and persistent morphine-induced respiratory depression associated with ATP-Binding Cassette Subfamily B Member 1 and catechol-O-methyltransferase genetic defects: A case report | European Journal of Anaesthesiology | | 2018 | 445 | 352 | ||
| Screening for genotypic and phenotypic variations in CYP450 activity in patients with therapeutic problems in a psychiatric setting, a retrospective study | Pharmacological research | | 2017 | 661 | 185 | ||
| "Late" Withdrawal Syndrome after Carbamazepine In Utero Exposure in a CYP2C9 Slow Metabolizer Newborn | Frontiers in Pharmacology | | 2017 | 636 | 233 | ||
| Cefepime plasma concentrations and clinical toxicity: a retrospective cohort study | Clinical microbiology and infection | | 2017 | 641 | 4 | ||
| Maternal Mitochondrial Encephalomyopathy, Lactic Acidosis and Stroke-Like Episodes Syndrome and Neonatal Magnesium Toxicity: A Case Report | Gynecology and Obstetrics | | 2017 | 402 | 283 | ||
| Meta-xylene: identification of a new antigenic entity in hypersensitivity reactions to local anesthetics | Journal of allergy and clinical immunology. In practice | | 2016 | 663 | 1 | ||
| Rivaroxaban-Induced Hemorrhage Associated with ABCB1 Genetic Defect | Frontiers in pharmacology | | 2016 | 508 | 239 | ||
| Severe Vincristine-Induced Neuropathic Pain in a CYP3A5 Nonexpressor With Reduced CYP3A4/5 Activity: Case Study | Clinical therapeutics | | 2016 | 556 | 2 | ||
| Cannabinoïdes médicaux dans les douleurs chroniques : aspects pharmacologiques | Revue médicale suisse | | 2015 | 692 | 5 | ||
| Is pholcodine a dangerous cough suppressant? | European journal of anaesthesiology | | 2015 | 627 | 1 | ||
| Reversible ventricular arrythmia induced by dasatinib | Clinical case reports | | 2013 | 656 | 232 | ||
| Applications of CYP450 Testing in the Clinical Setting | Molecular diagnosis & therapy | | 2013 | 771 | 923 | ||
| Quel programme informatique de détection des interactions médicamenteuses néfastes ? | Revue médicale suisse | | 2012 | 978 | 976 | ||
| Validation of the simplified UVB model to assess the pharmacodynamics of analgesics in healthy human volunteers | Chimia | | 2012 | 805 | 1,160 | ||
| Pharmacokinetic-pharmacodynamic modelling of opioids in healthy human volunteers. A minireview | Basic & clinical pharmacology & toxicology | | 2012 | 653 | 723 | ||
| Fracture atypique du fémur sous bisphosphonates, un effet indésirable à ne pas manquer | Revue médicale suisse | | 2012 | 616 | 0 | ||
| Atypical femoral fracture following bisphosphonate treatment in a woman with osteogenesis imperfecta--a case report | Acta orthopaedica | | 2012 | 676 | 311 | ||
| Aspects pharmacodynamiques et pharmacocinétiques d'une combinaison de paracétamol et d'AINS | | 2011 | 1,671 | 12 | |||
| A randomized, controlled trial validates a peripheral supra-additive antihyperalgesic effect of a paracetamol-ketorolac combination | Basic & clinical pharmacology & toxicology | | 2011 | 677 | 0 | ||
| ABCB1 polymorphisms and neuropsychiatric adverse events in oseltamivir-treated children during influenza H1N1/09 pandemia | Pharmacogenomics | | 2011 | 952 | 6 | ||
| Two-dimensional liquid chromatography-ion trap mass spectrometry for the simultaneous determination of ketorolac enantiomers and paracetamol in human plasma: application to a pharmacokinetic study | Journal of chromatography | | 2009 | 562 | 0 | ||
| Low-energy femoral fractures associated with the long-term use of bisphosphonates: a case series from a Swiss university hospital | Drug safety | | 2009 | 623 | 0 |
